Richard A. Paulson - 08 Sep 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
President and CEO, Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Richard Paulson
Issuer symbol
KPTI
Transactions as of
08 Sep 2022
Net transactions value
-$18,196
Form type
4
Filing time
09 Sep 2022, 08:17:44 UTC
Previous filing
05 Aug 2022
Next filing
05 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $84.1 -16 -0% $5.26 626,461 08 Sep 2022 Direct F1
transaction KPTI Common Stock Sale $18,111 -3,463 -0.55% $5.23 622,998 08 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.